10,271 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Highland Capital Management LLC

Highland Capital Management LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,271 shares of the company's stock, valued at approximately $238,000.

Other hedge funds have also recently made changes to their positions in the company. UMB Bank n.a. raised its stake in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC grew its holdings in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its position in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after buying an additional 1,446 shares in the last quarter. International Assets Investment Management LLC raised its position in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after acquiring an additional 2,757 shares during the last quarter. Finally, Quarry LP raised its position in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after purchasing an additional 2,628 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company's stock in a transaction on Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research note on Friday, November 1st. UBS Group began coverage on Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price for the company. JPMorgan Chase & Co. lifted their price target on Option Care Health from $38.00 to $40.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and an average price target of $32.25.

Option Care Health Stock Up 0.8 %

OPCH stock traded up $0.26 during midday trading on Tuesday, hitting $30.95. 469,794 shares of the company's stock were exchanged, compared to its average volume of 1,948,554. The stock has a market capitalization of $5.27 billion, a price-to-earnings ratio of 26.08, a price-to-earnings-growth ratio of 2.19 and a beta of 1.35. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a 50 day moving average price of $25.46 and a 200-day moving average price of $27.87. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.